Rimfrost is a joint venture between krill harvester Olympic Seafood AS and extraction specialist Avoca Inc.
Olympic Seafood AS and Avoca Inc. (Merry Hill, NC) have formed a joint venture to produce Antarctic krill oil under the Rimfrost Krill Collection brand.
Olympic Seafood AS is a Norway-based krill harvester. The company uses a low-temperature, low-oxidation processing technology and recently earned Friend of the Sea certification for sustainable krill fishing. Its krill material will undergo extraction by Avoca Inc., a Pharmachem company that has performed extraction on krill for the last two years. Resulting krill oil will be produced under the venture name Rimfrost USA LLC.
“This venture will enable us to produce in the range of 600 tons of krill oil per year, which is equal to the estimated current annual worldwide demand,” said Avoca president David Peele. “It ensures our customers are receiving an extremely high quality krill oil, extracted in a GMP facility, with traceability from krill that are collected in an environmentally sustainable manner.”
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.